- The US naloxone market is estimated to be valued at USD$672.1 Mn in 2026 and is expected to reach USD$1.36 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033*
- Increasing prevalence of opioid use and the opioid epidemic have led to an increase in demand for naloxone as a means of preventing overdose deaths.
- Opioid overdose deaths per year in the USA have been declining as a result of the increased availability of Narcan® especially since being granted OTC status
- 10% market capture of just the U.S. spray market (~$608 M) equates to approximately $60 million annual revenue—without factoring Canada.
*https://www.coherentmarketinsights.com/market-insight/us-naloxone-market-4953
US Market Overview
| Geography | Market Size (2025) | Growth Drivers |
| U.S. | US$600–700M | OTC availability, opioid overdose epidemic, public health funding, retail pharmacy expansion. |
| Canada | US$60–80M | Provincial purchasing programs, expanding take-home naloxone initiatives, increasing public access. |
| Total Addressable Market (NA) | US$700–800M | Continued growth driven by overdose prevention policies and broader community distribution. |